A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].

Authors:
Hogg RJ; Wyatt RJ; Scientific Planning Committee of the North American IgA Nephropathy Study.

Journal:
BMC Nephrol

Publication Year: 2004

DOI:
10.1186/1471-2369-5-3

PMCID:
PMC415550

PMID:
15043759

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: BMC Nephrol

Detailed journal information not available.

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

2/6

0.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Competing interests None declared."

Funding Disclosure

Evidence found in paper:

"AcknowledgementsC. Martin Bunke, M.D. and Rob Gordon, M.D. of Roche Laboratories, Nutley, NJ provided valuable assistance in the development of this study. The study is supported by grant from Roche Laboratories. The Omacor® capsules are provided by Pronova Biocare, Lysaker, Norway. At the University of Tennessee Health Sciences Center this study is support by the General Clinical Research Center (USPHS-RR000211)."

Protocol Registration

Open Access

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025